Patient 05002, a 52-year-old woman diagnosed with advanced gastric cancer with ovarian implantation metastases, underwent multiple prior treatments, including EOX (epirubicin, oxaliplatin, and capecitabine) chemotherapy, sintilimab (an a-PD1 antibody), albumin paclitaxel, FOLFIRI (fluorouracil, folinic acid, and irinotecan) chemotherapy, and Tegio (a fluorouracil derivative). This evidence concerns the gene ALB and gastric cancer.